<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27319" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, Platelets</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williams</surname>
            <given-names>Olivia</given-names>
          </name>
          <aff>Queen Mary University of London</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sergent</surname>
            <given-names>Shane R.</given-names>
          </name>
          <aff>Michigan State University College of OM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Olivia Williams declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shane Sergent declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27319.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Platelets are the smallest blood cells,&#x000a0;typically around 2 &#x003bc;m in diameter and anucleated, with an average lifespan of 7&#x000a0;to 10 days in humans.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref><xref ref-type="bibr" rid="article-27319.r2">[2]</xref>&#x000a0;Platelets first gained recognition as having a role in hemostasis more than 100 years ago by the Italian pathologist Giulio Bizzozero, and significant progress was made in elucidating their role in hemostasis and thrombosis during the 20th century using light microscopy techniques.<xref ref-type="bibr" rid="article-27319.r3">[3]</xref>&#x000a0;More recently, advanced techniques such as electron microscopy and immunofluorescence have allowed far more detailed analysis of platelet ultrastructure and function.</p>
      </sec>
      <sec id="article-27319.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Platelets play a key role in hemostasis, and their dysfunction can result in a variety of inherited and acquired bleeding disorders. They also have involvement in the development of thrombi in the context of atherosclerosis, a pathological process associated with significant morbidity and mortality, primarily through myocardial infarction and stroke.&#x000a0;</p>
      </sec>
      <sec id="article-27319.s3" sec-type="Structure">
        <title>Structure</title>
        <p>Platelets form by the fragmentation of megakaryocytes within the bone marrow. Megakaryocytes duplicate in the marrow without dividing, resulting in the production of giant cells. Within these giant cells, organelles organize into discrete domains, which will eventually become individual platelets, separated by a network of invaginating plasma membranes. These megakaryocytes are positioned next to the sinusoidal walls so that shearing forces from circulating blood fragment the megakaryocyte cytoplasm into individual platelets and sweep these new platelets into the bloodstream.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref>&#x000a0;Platelets circulate in the blood in discoid form but undergo significant structural changes following activation, mediated by actin and myosin within the cytoplasm. The platelets transform from discoid forms into compact spheres with dendritic extensions, which allow platelet adhesion. A variety of membrane-bound glycoprotein receptors facilitates adhesion and aggregation of platelets.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref></p>
        <p>As described above, platelets are anuclear but do contain ribonucleic acid, ribosomes, mitochondria, and various granules, which are important in enacting platelet function.<xref ref-type="bibr" rid="article-27319.r2">[2]</xref> There are three distinct types of platelet granule</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x003b1;-granules: the most abundant and largest secretory granules, containing most of the platelet factors involved in hemostasis, including p-selectin, von Willebrand Factor, and fibrinogen&#x000a0;<xref ref-type="bibr" rid="article-27319.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Dense granules: the smallest granules, which are visible on electron microscopy as dense bodies and contain adenosine diphosphate and serotonin, as well as high levels of calcium&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lysosomes: contain hydrolytic enzymes, including acid phosphatase and arylsulfatase&#x000a0;<xref ref-type="bibr" rid="article-27319.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>An &#x02018;open canalicular system&#x02019; formed of deep surface membrane invaginations facilitates the secretion of granules.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref> This system also has a key role in the transport of membrane receptors, allowing them to cluster, stabilize platelet adhesion sites, and amplify signaling.<xref ref-type="bibr" rid="article-27319.r2">[2]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27319.s4" sec-type="Function">
        <title>Function</title>
        <p>Platelets have a crucial role in thrombus formation and hemostasis. Platelets circulate in the blood in a quiescent discoid form but may become activated by contact with damaged blood vessel walls. Following blood vessel damage, substances in the exposed subendothelial extracellular matrix, such as collagen and von Willebrand factor, may bind to platelet surface receptors.<xref ref-type="bibr" rid="article-27319.r6">[6]</xref> Platelets will adhere to&#x000a0;sites of injury, and receptor binding will lead to platelet activation.</p>
        <p>As described above, platelets&#x000a0;undergo a structural transformation at this point and begin to secrete granule contents to promote platelet aggregation and platelet plug formation. Activated platelets release factors such as ADP, thromboxane A2, and thrombin, which can promote the activation of other nearby platelets in a positive feedback mechanism.<xref ref-type="bibr" rid="article-27319.r7">[7]</xref>&#x000a0;Activation also leads to the surface expression of glycoprotein IIb-IIIa. This protein binds to fibrinogen, allowing cross-linking of platelets and mediating platelet aggregation.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref>&#x000a0;A final change during activation is the expression of phosphatidylserine, which generates a negative charge on platelet surfaces. This negative charge allows clotting factor complexes to assemble on the surface as part of the secondary hemostasis response.<xref ref-type="bibr" rid="article-27319.r2">[2]</xref></p>
        <p>The above processes ultimately lead to the production of a thrombus: a structure formed of aggregated, activated platelets combined with a mesh of cross-linked fibrin and entrapped erythrocytes and leukocytes. This thrombus restores the structural integrity of the damaged vessel wall and prevents blood loss while the vessel heals. There is additional growing evidence of the role of platelets in inflammatory and immune responses. Leukocytes are recruited to thrombi via interactions with platelet P-selectin, and platelet &#x003b1;-granules contain a range of pro-inflammatory cytokines. Antiplatelet medications have been found to affect immunity and may even reduce mortality related to infection and sepsis.<xref ref-type="bibr" rid="article-27319.r8">[8]</xref></p>
      </sec>
      <sec id="article-27319.s5" sec-type="Tissue Preparation">
        <title>Tissue Preparation</title>
        <p>Platelets are most commonly visualized via a peripheral blood film. Blood can either be taken directly from a finger prick or a venous sample stored in an anticoagulant blood bottle. The blood smear requires preparation without excessive delay following obtaining the sample, as delay can lead to clumping of platelets and pseudothrombocytopenia. Blood should be smeared thinly onto a slide to produce a monolayer of cells and allowed to dry. Once dry, the smear should be fixed with alcohol and stained.<xref ref-type="bibr" rid="article-27319.r9">[9]</xref></p>
        <p>For functional platelet studies, washed platelet suspensions are often necessary. Platelets are sequentially centrifuged and resuspended in a buffer solution (Tyrode&#x02019;s albumin buffer) to isolate them from the plasma and clotting factors that normally surround them. This process allows examination of the intrinsic properties of the platelets in a controlled suspension rather than of the interaction between platelets and their natural plasma environment.<xref ref-type="bibr" rid="article-27319.r3">[3]</xref></p>
      </sec>
      <sec id="article-27319.s6" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>Romanowsky stains, such as Wright-Giemsa are typically used in blood films to produce differential staining of blood components, with platelets staining blue.<xref ref-type="bibr" rid="article-27319.r10">[10]</xref>&#x000a0;The platelet color and granular appearance on light microscopy are a result of the&#x000a0;&#x003b1;-granules, which are azurophilic&#x000a0;and comprise about 10% of the total platelet volume.<xref ref-type="bibr" rid="article-27319.r4">[4]</xref><xref ref-type="bibr" rid="article-27319.r11">[11]</xref>&#x000a0;Disorders that lead to a reduction in the number of azurophilic &#x003b1;-granules result in the pale-looking cells of &#x0201c;gray platelet syndrome.&#x0201d;<xref ref-type="bibr" rid="article-27319.r11">[11]</xref>&#x000a0;Other stains may be needed to differentiate between different structures even when carrying out detailed electron microscopy assessment. The electron density of lysosomes and &#x003b1;-granules are very similar, but tests for the presence of lysosomal enzymes, such as acid phosphatase staining and arylsulfatase localization, can differentiate the 2.<xref ref-type="bibr" rid="article-27319.r12">[12]</xref></p>
      </sec>
      <sec id="article-27319.s7" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>Quantitative platelet disorders (ie, thrombocytopenia and thrombocytosis) are readily diagnosable using light microscopy, while qualitative disorders are more difficult, especially given the small size of typical platelets. Though platelets are too small for detailed assessment via light microscopy, some basic evaluations are possible in terms of size and morphology. Large platelets are usually the result of megakaryocyte hyperactivity. Younger (larger) reticulated platelets can be produced more quickly and so&#x000a0;might be seen in conditions where there is increased demand for platelet production.&#x000a0;Large&#x000a0;platelets are also present in some&#x000a0;inherited conditions, where platelets as big as a typical red blood cell may be visible.<xref ref-type="bibr" rid="article-27319.r9">[9]</xref></p>
        <p>In the diagnosis of suspected inherited platelet disorders, diagnostic protocols have undergone development, which involves initial assessment via traditional blood film with light microscopy, followed by more specific testing guided by the blood film findings. For example, if a blood film demonstrates large platelets, targeted immunofluorescence testing may be carried out against glycoprotein Ib (absence of which may indicate a diagnosis of Bernard-Soulier syndrome) or filamin 1A (absence of which may indicate filamin A-related thrombocytopenia). Normal-sized platelets can be tested for surface GPIIb/IIIa, which is lacking in Glanzmann thrombasthenia. &#x003b2;1-tubulin can also be visualized via immunofluorescence in small platelets, with abnormal bent forms of the protein indicating Wiskott-Aldrich syndrome or X-linked thrombocytopenia.<xref ref-type="bibr" rid="article-27319.r11">[11]</xref></p>
      </sec>
      <sec id="article-27319.s8" sec-type="Microscopy, Electron&#x0000d;&#x0000a;">
        <title>Microscopy, Electron
</title>
        <p>Electron microscopy can provide a detailed assessment of platelet ultrastructure and is important in the diagnosis of various platelet disorders. Three separate platelet ultrastructural compartments can be described on electron microscopy: cytoplasmic granules, platelet membranes, and the cytoskeleton.<xref ref-type="bibr" rid="article-27319.r13">[13]</xref>&#x000a0;Platelet ultrastructure and function are described above, and it is clear that abnormalities in any of these three functional compartments may result in&#x000a0;abnormal function (thrombocytopathy). Electron microscopy can visualize these structures and identify many of these abnormalities.</p>
        <p>&#x0201c;Grey platelet syndrome&#x0201d; may be suspected based on reduced staining on initial light microscopy, but electron microscopy can reveal an absence of &#x003b1;-granules and the presence of empty &#x003b1;-granule-sized vacuoles. Bernard-Soulier syndrome results from a defect in the GPIb/V/IX receptor, and when examined under electron microscopy, a variety of abnormalities may present, such as giant cell size, dilated surface-connected canalicular system, disorganized microtubules, and reduced granule numbers. MYH9-related disorders result in platelets with a similar giant size but otherwise normal ultrastructure on electron microscopy.<xref ref-type="bibr" rid="article-27319.r13">[13]</xref></p>
      </sec>
      <sec id="article-27319.s9" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Because of platelets&#x02019; essential role in hemostasis, platelet pathology correlates with excessive bleeding. Patients with thrombocytopenia or reduced platelet function tend to present with petechiae and mucocutaneous bleeding. Following small endothelial lesions, primary hemostasis is often ineffective, and so bleeding, such as epistaxis, gingival bleeding, and purpura occur. Patients with coagulation disorders such as Haemophilia, on the other hand, tend not to experience excessive bleeding from small cuts but struggle to control larger bleeds where fibrin reinforcement of the primary clot is required.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref></p>
        <p>Platelet abnormalities are categorized&#x000a0;into quantitative disorders (thrombocytopenia or thrombocytosis) and qualitative disorders (thrombasthenias). Thrombocytopenia is common and usually acquired. Common causes include hypersplenism, drugs (e.g., heparin-induced thrombocytopenia), infections, pregnancy, and immune thrombocytopenia. Hereditary thrombocytopenias are rare but merit consideration, especially if giant platelets are visible on the blood film.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref>&#x000a0;Thrombocytosis is also common, with&#x000a0;88&#x000a0;to 97% of cases attributed as reactive in origin and the remainder being clonal disorders and spurious results.<xref ref-type="bibr" rid="article-27319.r14">[14]</xref> A wide variety of thrombasthenias have been identified, with some examples provided above. Platelets are also involved in the pathophysiology of atherosclerosis.&#x000a0;They play an obvious role in thrombus formation on the surface of a ruptured plaque in response to the exposure of subendothelial structures. Platelets also appear to be involved in the recruitment of leukocytes to plaques during their formation through cytokine release and receptor-ligand interactions.<xref ref-type="bibr" rid="article-27319.r15">[15]</xref></p>
      </sec>
      <sec id="article-27319.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>An understanding of platelet function and pathophysiology is essential in the diagnosis and management of both bleeding disorders and pathological thrombus formation in atherosclerosis (see <bold>Image.</bold>&#x000a0;Red Blood Cell, Platelet, and White Blood Cell). Though platelet disorders can lead to excessive bleeding, as described above, it is important to note that platelet numbers generally need to be drastically reduced before spontaneous bleeding starts. Normal platelet levels in adults are between 150&#x000a0;to 350x10^9/L, but spontaneous bleeding often does not occur until the platelet count drops below 10x10^9/L (assuming normal platelet function). Bleeding symptoms may also be sporadic, even in severe functional platelet disorders, such as Glanzmann thrombasthenia, where the important glycoprotein IIb-IIIa is undetectable.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref>&#x000a0;The underlying cause of the reduced platelet number or platelet dysfunction should be addressed as first-line, with platelet transfusions being a consideration if platelet counts drop below a critical threshold or in the context of life-threatening bleeding.<xref ref-type="bibr" rid="article-27319.r16">[16]</xref></p>
        <p>Antiplatelet medications are commonly used in the management of atherosclerotic coronary artery and cerebrovascular disease&#x02014;aspirin results in irreversible inhibition of the cyclo-oxygenase enzyme, which has a role in thromboxane formation. In patients with otherwise normal platelet function, aspirin results in a modest increase in bleeding risk, but its use is widespread because of its effectiveness in both the treatment and prevention of myocardial infarction and stroke.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref>&#x000a0;Other medications, such as ticagrelor and clopidogrel, block the PY212 ADP receptor.<xref ref-type="bibr" rid="article-27319.r15">[15]</xref>&#x000a0;Glycoprotein IIb-IIIa receptor blockers such as eptifibatide and tirofiban are also extremely effective antithrombotic agents but carry a risk of significant thrombocytopaenia.<xref ref-type="bibr" rid="article-27319.r1">[1]</xref></p>
      </sec>
      <sec id="article-27319.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27319&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27319">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27319/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27319">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27319.s12">
        <fig id="article-27319.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Red Blood Cell, Platelet, and White Blood Cell. This illustration shows the different shapes and sizes of the red and white blood cells and a platelet. Contributed by C Rowe</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="platelets__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27319.s13">
        <title>References</title>
        <ref id="article-27319.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Platelets.</article-title>
            <source>Lancet</source>
            <year>2000</year>
            <month>Apr</month>
            <day>29</day>
            <volume>355</volume>
            <issue>9214</issue>
            <fpage>1531</fpage>
            <page-range>1531-9</page-range>
            <pub-id pub-id-type="pmid">10801186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montague</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Gardiner</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Imaging Platelet Processes and Function-Current and Emerging Approaches for Imaging <italic>in vitro</italic> and <italic>in vivo</italic>.</article-title>
            <source>Front Immunol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>78</fpage>
            <pub-id pub-id-type="pmid">32082328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hechler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dupuis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mangin</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Gachet</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects.</article-title>
            <source>Res Pract Thromb Haemost</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>615</fpage>
            <page-range>615-625</page-range>
            <pub-id pub-id-type="pmid">31624781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blair</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flaumenhaft</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Platelet alpha-granules: basic biology and clinical correlates.</article-title>
            <source>Blood Rev</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>177</fpage>
            <page-range>177-89</page-range>
            <pub-id pub-id-type="pmid">19450911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rendu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brohard-Bohn</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The platelet release reaction: granules' constituents, secretion and functions.</article-title>
            <source>Platelets</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>261</fpage>
            <page-range>261-73</page-range>
            <pub-id pub-id-type="pmid">11487378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holinstat</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Normal platelet function.</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-198</page-range>
            <pub-id pub-id-type="pmid">28667366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yun</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Goh</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Platelet Activation: The Mechanisms and Potential Biomarkers.</article-title>
            <source>Biomed Res Int</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>9060143</fpage>
            <pub-id pub-id-type="pmid">27403440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Storey</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>The role of platelets in inflammation.</article-title>
            <source>Thromb Haemost</source>
            <year>2015</year>
            <month>Aug</month>
            <day>31</day>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>449</fpage>
            <page-range>449-58</page-range>
            <pub-id pub-id-type="pmid">26293514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adewoyin</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Nwogoh</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Peripheral blood film - a review.</article-title>
            <source>Ann Ib Postgrad Med</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-9</page-range>
            <pub-id pub-id-type="pmid">25960697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horobin</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Understanding Romanowsky staining. I: The Romanowsky-Giemsa effect in blood smears.</article-title>
            <source>Histochemistry</source>
            <year>1987</year>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>331</fpage>
            <page-range>331-6</page-range>
            <pub-id pub-id-type="pmid">2437082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greinacher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pecci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kunishima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Althaus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nurden</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Balduini</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bakchoul</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders.</article-title>
            <source>J Thromb Haemost</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>1511</fpage>
            <page-range>1511-1521</page-range>
            <pub-id pub-id-type="pmid">28457011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bentfeld-Barker</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bainton</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Identification of primary lysosomes in human megakaryocytes and platelets.</article-title>
            <source>Blood</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>472</fpage>
            <page-range>472-81</page-range>
            <pub-id pub-id-type="pmid">6277410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clauser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cramer-Bord&#x000e9;</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Role of platelet electron microscopy in the diagnosis of platelet disorders.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-23</page-range>
            <pub-id pub-id-type="pmid">19408194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleeker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.</article-title>
            <source>Thrombosis</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>536062</fpage>
            <pub-id pub-id-type="pmid">22084665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kleiman</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Platelet pathophysiology, pharmacology, and function in coronary artery disease.</article-title>
            <source>Coron Artery Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>614</fpage>
            <page-range>614-623</page-range>
            <pub-id pub-id-type="pmid">28644213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27319.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Heal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Platelet transfusions: trigger, dose, benefits, and risks.</article-title>
            <source>F1000 Med Rep</source>
            <year>2010</year>
            <month>Jan</month>
            <day>27</day>
            <volume>2</volume>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">20502614</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
